| P2093 | author name string | Haibin Zhang | |
| | James J Pestka | |
| | Hui-Ren Zhou | |
| | Brenna Flannery | |
| | Jane E Link | |
| | Melissa A Bates | |
| | Steven J Bursian | |
| | Wenda Wu | |
| P2860 | cites work | The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y₂ receptor | Q84624399 |
| | Distribution of 5-hydroxytryptamine (serotonin, enteramine) in the wall of the digestive tract | Q24544046 |
| | Central neurocircuitry associated with emesis | Q28212287 |
| | Distribution of pancreatic polypeptide and peptide YY | Q28217249 |
| | The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity | Q28244059 |
| | Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron | Q28376551 |
| | The food-contaminant deoxynivalenol modifies eating by targeting anorexigenic neurocircuitry | Q28743954 |
| | Effect of processing on Fusarium mycotoxins. | Q33639631 |
| | Central mechanisms of vomiting. | Q33734237 |
| | The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight | Q33835949 |
| | Serotonin: a mediator of the brain-gut connection | Q34070408 |
| | Neurochemistry and neuropharmacology of emesis - the role of serotonin | Q34088863 |
| | Gut hormone PYY(3-36) physiologically inhibits food intake | Q34143493 |
| | Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions | Q34567394 |
| | Effects of cholecystokinin-8s in the nucleus tractus solitarius of vagally deafferented rats | Q34708002 |
| | The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells | Q34783985 |
| | Characterization of deoxynivalenol-induced anorexia using mouse bioassay | Q35070893 |
| | Predicting the emetic liability of novel chemical entities: a comparative study | Q36025372 |
| | PYY(3-36) induces Fos in the arcuate nucleus and in both catecholaminergic and non-catecholaminergic neurons in the nucleus tractus solitarius of rats | Q36416123 |
| | A role for endogenous peptide YY in tachykinin NK(2) receptor-triggered 5-HT release from guinea pig isolated colonic mucosa | Q36419333 |
| | Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases. | Q36429871 |
| | Comparison of emetic potencies of the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol, 3-acetyldeoxynivalenol, fusarenon X, and nivalenol | Q36509050 |
| | Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY | Q36752713 |
| | Tissue distribution and proinflammatory cytokine gene expression following acute oral exposure to deoxynivalenol: comparison of weanling and adult mice | Q37050091 |
| | Immunochemical assessment of deoxynivalenol tissue distribution following oral exposure in the mouse | Q37227550 |
| | Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonists | Q37761329 |
| | Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance | Q37783539 |
| | Neural mechanisms of emesis | Q37905191 |
| | Regulatory peptides and the onset of nausea and vomiting. | Q37905202 |
| | Area postrema: chemoreceptor circumventricular organ of the medulla oblongata | Q38646128 |
| | The neurophysiology of vomiting | Q39647441 |
| | Emetic and refusal activity of deoxynivalenol to swine | Q40074518 |
| | Isolation of the emetic principle from Fusarium-infected corn | Q40728837 |
| | Regulation of hindbrain Pyy expression by acute food deprivation, prolonged caloric restriction, and weight loss surgery in mice | Q41831322 |
| | In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor | Q42463764 |
| | Central inflammation and sickness-like behavior induced by the food contaminant deoxynivalenol: a PGE2-independent mechanism | Q42727255 |
| | Effect of gingerol on substance P and NK1 receptor expression in a vomiting model of mink. | Q43145965 |
| | Antiemetic effect of Xiao-Ban-Xia-Tang, a Chinese medicinal herb recipe, on cisplatin-induced acute and delayed emesis in minks | Q43185388 |
| | Plasma levels of peptide YY correlate with cisplatin-induced emesis in dogs | Q43416084 |
| | Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin. | Q43738036 |
| | Slowing intestinal transit by PYY depends on serotonergic and opioid pathways | Q44344804 |
| | Emetic activity of the trichothecene 15-acetyldeoxynivalenol in swine | Q44746698 |
| | Neurons in the nucleus of the solitary tract mediating inputs from emetic vagal afferents and the area postrema to the pattern generator for the emetic act in dogs | Q44971610 |
| | Gingerol inhibits cisplatin-induced vomiting by down regulating 5-hydroxytryptamine, dopamine and substance P expression in minks. | Q46029360 |
| | The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway | Q46464837 |
| | Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in Suncus murinus and ferrets | Q46633848 |
| | Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques | Q46774728 |
| | Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults | Q47298315 |
| | Cholecystokinin stimulates gonadotropin-releasing hormone release in the monkey (Macaca mulatta). | Q48311666 |
| | Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult rat. | Q48379863 |
| | The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats | Q49036890 |
| | The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety | Q50122116 |
| | Sensitivity of vagal mucosal afferents to cholecystokinin and its role in afferent signal transduction in the rat. | Q51556502 |
| | Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema. | Q51898125 |
| | Overt signs of toxicity to dogs and cats of dietary deoxynivalenol. | Q52177412 |
| | The mycotoxin, deoxynivalenol, delays gastric emptying through serotonin-3 receptors in rodents. | Q52516709 |
| | Effects of PYY1–36 and PYY3–36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects | Q58448409 |
| | 5-Hydroxytryptamine in the Circulation of the Dog | Q59053681 |
| | Mysterious outbreaks of gastrointestinal illness associated with burritos supplied through school lunch programs | Q64130418 |
| | The CCK-A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats | Q67591186 |
| | Identification and characterization of the emetic effects of peptide YY | Q69658041 |
| | Antiemetic properties of the 5HT3-receptor antagonist, GR38032F | Q70047869 |
| | The effect of deoxynivalenol on serotoninergic neurotransmitter levels in pig blood | Q71661418 |
| | Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing | Q72122579 |
| | The efficacy of various classes of anti-emetics in preventing deoxynivalenol-induced vomiting in swine | Q72385987 |
| | Outbreaks of gastrointestinal illness of unknown etiology associated with eating burritos--United States, October 1997-October 1998 | Q74659185 |
| | Distribution of serotonin (5-hydroxytryptamine) in the human gastrointestinal tract | Q78991060 |
| | Effects of PYY[3-36] in rodent models of diabetes and obesity | Q80201001 |
| | Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice | Q80959476 |
| P433 | issue | 1 | |
| P921 | main subject | deoxynivalenol | Q420518 |
| P304 | page(s) | 186-195 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Toxicological Sciences | Q2446966 |
| P1476 | title | Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin). | |
| P478 | volume | 133 | |